VCAM-TARGETED DELIVERY OF RECOMBINANT CD39 TO THE ENDOTHELIUM IS ANTITHROMBOTIC, ANTIINFLAMMATORY AND AMELIORATES ISCHAEMIA REPERFUSION INJURY. Grant uri icon

Overview

Grant awarded by

  • NHMRC

Sponsor award id

  • 1083006

Awards

Time

Date/time interval

  • 2015

Other

Scheme

  • Project Grants